Carol Beadling

4.9k total citations
65 papers, 3.0k citations indexed

About

Carol Beadling is a scholar working on Molecular Biology, Cancer Research and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Carol Beadling has authored 65 papers receiving a total of 3.0k indexed citations (citations by other indexed papers that have themselves been cited), including 26 papers in Molecular Biology, 25 papers in Cancer Research and 21 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Carol Beadling's work include Cancer Genomics and Diagnostics (16 papers), Breast Lesions and Carcinomas (8 papers) and Gastrointestinal Tumor Research and Treatment (8 papers). Carol Beadling is often cited by papers focused on Cancer Genomics and Diagnostics (16 papers), Breast Lesions and Carcinomas (8 papers) and Gastrointestinal Tumor Research and Treatment (8 papers). Carol Beadling collaborates with scholars based in United States, United Kingdom and India. Carol Beadling's co-authors include Mark K. Slifka, Christopher L. Corless, Andrea Warrick, Michael C. Heinrich, Doreen A. Cantrell, Kendall A. Smith, Tanaya Neff, Janice Patterson, Dmitry Guschin and Ian M. Kerr and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Nature Medicine and The Journal of Experimental Medicine.

In The Last Decade

Carol Beadling

65 papers receiving 3.0k citations

Peers

Countries citing papers authored by Carol Beadling

Since Specialization

Citations

This map shows the geographic impact of Carol Beadling's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Carol Beadling with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Carol Beadling more than expected).

Fields of papers citing papers by Carol Beadling

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Carol Beadling. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Carol Beadling. The network helps show where Carol Beadling may publish in the future.

Co-authorship network of co-authors of Carol Beadling

This figure shows the co-authorship network connecting the top 25 collaborators of Carol Beadling. A scholar is included among the top collaborators of Carol Beadling based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Carol Beadling. Carol Beadling is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Molecular profiling of pre- and post-treatment pediatric high-grade astrocytomas reveals acquired increased tumor mutation burden in a subset of recurrences 2023 ·Acta Neuropathologica Communications ·Matthew D. Wood, Carol Beadling, Tanaya Neff, (unknown), Christina A. Harrington, Lissa Baird, Christopher L. Corless	3
2	Characterizing advanced breast cancer heterogeneity and treatment resistance through serial biopsies and comprehensive analytics 2021 ·npj Precision Oncology ·Allen Li, Jamie M. Keck, Swapnil Parmar, Janice Patterson, Marilyne Labrie, Allison Creason, Brett Johnson, (unknown), George Thomas, Carol Beadling, Laura M. Heiser, Annette Kolodzie, Alexander R. Guimarães, Christopher L. Corless, Joe W. Gray, Gordon B. Mills, Raymond C. Bergan, Zahi Mitri	23
3	Biochemical, Molecular, and Clinical Characterization of Succinate Dehydrogenase Subunit A Variants of Unknown Significance 2017 ·Clinical Cancer Research ·(unknown), (unknown), Isaac Forquer, Ajia Town, Lillian R. Klug, Kelly McCann, Carol Beadling, (unknown), Jason K. Sicklick, Christopher L. Corless, Ujwal Shinde, Michael C. Heinrich	11
4	Durable Response to Afatinib in Lung Adenocarcinoma Harboring NRG1 Gene Fusions 2017 ·Journal of Thoracic Oncology ·(unknown), Ying Wang, Carol Beadling, Andrea Warrick, Tanaya Neff, Christopher L. Corless, Khaled Tolba	56
5	Combination Therapy for KIT -Mutant Mast Cells: Targeting Constitutive NFAT and KIT Activity 2014 ·Molecular Cancer Therapeutics ·(unknown), Lillian R. Klug, Janice Patterson, Diana Griffith, Carol Beadling, Ajia Town, Michael C. Heinrich	6
6	Novel Mutations in Neuroendocrine Carcinoma of the Breast 2014 ·Applied immunohistochemistry & molecular morphology ·Daphne Ang, (unknown), Carol Beadling, Andrea Warrick, (unknown), (unknown), (unknown), Tanaya Neff, Robert B. West, Christopher L. Corless, Megan L. Troxell	44
7	Oncogenic mutations in melanomas and benign melanocytic nevi of the female genital tract 2014 ·Journal of the American Academy of Dermatology ·Diane Tseng, Julie Kim, Andrea Warrick, Dylan Nelson, (unknown), Carol Beadling, Michael C. Heinrich, Maria Angelica Selim, Christopher L. Corless, Kelly C. Nelson	26
8	Genetic Profiling to Determine Risk of Relapse-Free Survival in High-Risk Localized Prostate Cancer 2013 ·Clinical Cancer Research ·Christine M. Barnett, Michael C. Heinrich, Jeong Ho Lim, Dylan Nelson, Carol Beadling, Andrea Warrick, Tanaya Neff, Celestia S. Higano, Mark Garzotto, David Z. Qian, Christopher L. Corless, George Thomas, Tomasz M. Beer	19
9	Frequent phosphatidylinositol-3-kinase mutations in proliferative breast lesions 2013 ·Modern Pathology ·Daphne Ang, Andrea Warrick, (unknown), Carol Beadling, Christopher L. Corless, Megan L. Troxell	35
10	Frequent PIK3CA Mutations in Radial Scars 2013 ·Diagnostic Molecular Pathology ·(unknown), Daphne Ang, Andrea Warrick, Carol Beadling, Christopher L. Corless, Megan L. Troxell	15
11	Novel Method for PIK3CA Mutation Analysis 2013 ·Journal of Molecular Diagnostics ·Daphne Ang, (unknown), (unknown), Carol Beadling, Andrea Warrick, Megan L. Troxell, Christopher L. Corless	22
12	Mucinous breast carcinomas lack PIK3CA and AKT1 mutations 2012 ·Human Pathology ·Elizabeth Kehr, Julie M. Jorns, Daphne Ang, Andrea Warrick, Tanaya Neff, (unknown), Rebecca Lewis, Carol Beadling, Christopher L. Corless, Megan L. Troxell	31
13	Combining Highly Multiplexed PCR with Semiconductor-Based Sequencing for Rapid Cancer Genotyping 2012 ·Journal of Molecular Diagnostics ·Carol Beadling, Tanaya Neff, Michael C. Heinrich, Katherine Rhodes, Michael Thornton, John H. Leamon, Mark T. Andersen, Christopher L. Corless	91
14	Cytokine-Mediated Programmed Proliferation of Virus-Specific CD8+ Memory T Cells 2012 ·Immunity ·Hans-Peter Raué, Carol Beadling, (unknown), Mark K. Slifka	71
15	Phosphatidylinositol-3-kinase pathway mutations are common in breast columnar cell lesions 2012 ·Modern Pathology ·Megan L. Troxell, Alayne Brunner, Tanaya Neff, Andrea Warrick, Carol Beadling, Kelli Montgomery, Shirley Zhu, Christopher L. Corless, Robert B. West	33
16	BRAF and KRAS Mutations in Sporadic Glomus Tumors 2012 ·American Journal of Dermatopathology ·(unknown), Andrea Warrick, Dylan Nelson, Carol Beadling, Christopher L. Corless	35
17	Regulation of innate and adaptive immune responses by the related cytokines IL-12, IL-23, and IL-27 2006 ·Archivum Immunologiae et Therapiae Experimentalis ·Carol Beadling, Mark K. Slifka	74
18	How do viral infections predispose patients to bacterial infections? 2004 ·Current Opinion in Infectious Diseases ·Carol Beadling, Mark K. Slifka	144
19	A monoclonal mouse anti-human IL-2 receptor antibody (anti-Tac) will recognize molecules on the surface of Xenopus laevis immunocytes which specifically bind rIL-2 and are only slightly larger than the human Tac protein 1990 ·Immunology Letters ·Laurens N. Ruben, Lorene K. Langeberg, Arthur Malley, Richard H. Clothier, Carol Beadling, (unknown), Stanley M. Shiigi	2
20	Differential induction of H-2K versus H-2D class I major histocompatibility antigens by recombinant gamma interferon. Lack of Kk augmentation in a leukemia virus-induced tumor is due to a cis-dominant effect. 1988 ·The Journal of Experimental Medicine ·(unknown), (unknown), Carol Beadling	10

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact